239 related articles for article (PubMed ID: 25944005)
1. CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.
Wang F; Yang L; Gao Q; Huang L; Wang L; Wang J; Wang S; Zhang B; Zhang Y
Cancer Immunol Immunother; 2015 Aug; 64(8):965-76. PubMed ID: 25944005
[TBL] [Abstract][Full Text] [Related]
2. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
[TBL] [Abstract][Full Text] [Related]
3. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses.
Liu Q; Ou Q; Chen H; Gao Y; Liu Y; Xu Y; Ruan Q; Zhang W; Shao L
BMC Infect Dis; 2019 Nov; 19(1):1006. PubMed ID: 31779590
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of CD206
Pei XB; Wu XZ; Yi FS; Zhai K; Shi HZ
J Thorac Dis; 2019 Jul; 11(7):2730-2736. PubMed ID: 31463100
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.
Gao J; Song L; Li D; Peng L; Ding H
Medicine (Baltimore); 2019 Oct; 98(42):e17416. PubMed ID: 31626097
[TBL] [Abstract][Full Text] [Related]
6. Antibody combinations for optimized staining of macrophages in human lung tumours.
Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134
[TBL] [Abstract][Full Text] [Related]
7. Monocytes subtypes from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy.
Luo L; Deng S; Tang W; Hu X; Yin F; Ge H; Tang J; Liao Z; Feng J; Li X; Mo B
J Clin Lab Anal; 2022 Aug; 36(8):e24579. PubMed ID: 35819097
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.
Tippett E; Cheng WJ; Westhorpe C; Cameron PU; Brew BJ; Lewin SR; Jaworowski A; Crowe SM
PLoS One; 2011; 6(5):e19968. PubMed ID: 21625498
[TBL] [Abstract][Full Text] [Related]
9. A Multiparameter Flow Cytometry Analysis Panel to Assess CD163 mRNA and Protein in Monocyte and Macrophage Populations in Hyperinflammatory Diseases.
Thornton S; Tan R; Sproles A; Do T; Schick J; Grom AA; DeLay M; Schulert GS
J Immunol; 2019 Mar; 202(5):1635-1643. PubMed ID: 30683706
[TBL] [Abstract][Full Text] [Related]
10. CD163: a specific immunohistochemical marker for acute myeloid leukemia with monocytic differentiation.
Garcia C; Gardner D; Reichard KK
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):417-21. PubMed ID: 18542032
[TBL] [Abstract][Full Text] [Related]
11. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
12. CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression.
Fischer-Smith T; Tedaldi EM; Rappaport J
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):417-21. PubMed ID: 18373432
[TBL] [Abstract][Full Text] [Related]
13. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
[TBL] [Abstract][Full Text] [Related]
14. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
[TBL] [Abstract][Full Text] [Related]
15. Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis.
Daghestani HN; Pieper CF; Kraus VB
Arthritis Rheumatol; 2015 Apr; 67(4):956-65. PubMed ID: 25544994
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of monocyte enumeration by flow cytometry: improved detection by combining monocyte-related antibodies with anti-CD163.
Zarev PV; Davis BH
Lab Hematol; 2004; 10(1):24-31. PubMed ID: 15070214
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating M2-like monocytes in patients with breast cancer.
Zhang B; Cao M; He Y; Liu Y; Zhang G; Yang C; Du Y; Xu J; Hu J; Gao F
Tumour Biol; 2017 Jun; 39(6):1010428317711571. PubMed ID: 28639912
[TBL] [Abstract][Full Text] [Related]
18. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.
Tian T; Li J; Hu W; Sun C; Zhou J
J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967
[TBL] [Abstract][Full Text] [Related]
19. Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer.
Biaoxue R; Min L; Tian F; Wenlong G; Hua L
BMC Pulm Med; 2018 Dec; 18(1):188. PubMed ID: 30522463
[TBL] [Abstract][Full Text] [Related]
20. Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score.
Chantharakhit C; Sujaritvanichpong N
Asian Pac J Cancer Prev; 2022 Jan; 23(1):25-31. PubMed ID: 35092368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]